0.75Open0.75Pre Close0 Volume47 Open Interest2.00Strike Price0.00Turnover778.24%IV109.92%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier21DDays to Expiry0.75Extrinsic Value100Contract SizeAmericanOptions Type0.7604Delta0.1271Gamma1.75Leverage Ratio-0.0185Theta0.0001Rho1.33Eff Leverage0.0010Vega
NRX Pharmaceuticals Stock Discussion
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Publication of Paper Entitled "Quality Assurance of Depression Ratings in Psychiatric Clinical Trials"
NRx Pharmaceuticals announced the publication of a paper in the American Journal of Clinical Psychopharmacology highlighting their improved methodology for depression rating quality assurance in clinical trials. The company developed an enhanced training and monitoring program for study site raters that achieved 94.5...
2 MINUTES AGO, 7:47 AM EDT
VIA PR NEWSWIRE
• The clinics are located in favorable locations, are revenue generating and EBITDA positive
• Clinics offer a comprehensive range of mental health services
• Acquisition is expected to be immediately accretive to revenue and EBITDA for HOPE and NRx
Larger Image: tradingview.com...
$NRX Pharmaceuticals (NRXP.US)$
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire a Premier West Coast Interventional Psychiatric Clinic | NRXP Stock News
No comment yet